The USPSTF released a statement on the benefits and harms of screening for celiac disease in asymptomatic adults, adolescents, and children 3-years and older.
A new study extended the period of treatment for patients with Hepatitis C on Sofosbuvir and Ribavirin to test whether SVF12 rates can be attained in real-life.
In a recent meta-analysis, researchers investigated the risk of gastrointestinal bleeding with daily aspirin use, specifically examining the risk of fatal events attributable to low-dose aspirin.
Researchers assessed direct-acting antiviral agents and availability of funding to determine the impact on ability to treat and cure veterans with hepatitis C virus.